MedTrace Logo

Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients

NCT02122874 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-04-25

No results posted yet for this study

Summary

Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients

Conditions

  • Diabetes Mellitus Type 2 in Obese
  • Type 2 Diabetes Mellitus With Features of Insulin Resistance

Interventions

DEVICE

Percutaneous Neurostimulation (PENS) of dermatome T7

The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet

OTHER

1200 Kcal diet

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02122874 on ClinicalTrials.gov